Yan-yan Lu

The State Key Laboratory Of Pharmaceutical Biotechnology
Nanjing, 210008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

ADT-OH inhibits malignant melanoma metastasis in mice via suppressing CSE/CBS and FAK/Paxillin signaling pathway.

ADT-OH inhibits malignant melanoma metastasis in mice via suppressing CSE/CBS and FAK/Paxillin signaling pathway.

Journal: Acta pharmacologica Sinica

Published: May 26, 2021

Clinical observations on associations between the UGT1A1 genotype and severe toxicity of irinotecan.

Clinical observations on associations between the UGT1A1 genotype and severe toxicity of irinotecan.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: May 13, 2014

Comparison of efficacy and toxicity of first line chemotherapy with or without epirubicin for patients with advanced stage soft tissue sarcoma.

Comparison of efficacy and toxicity of first line chemotherapy with or without epirubicin for patients with advanced stage soft tissue sarcoma.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: January 28, 2014

Pemetrexed as a component of first-, second- and third- line chemotherapy in treating patients with metastatic lung adenocarcinoma.

Pemetrexed as a component of first-, second- and third- line chemotherapy in treating patients with metastatic lung adenocarcinoma.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: January 01, 2014

Phase II study on Javanica oil emulsion injection (Yadanzi®) combined with chemotherapy in treating patients with advanced lung adenocarcinoma.

Phase II study on Javanica oil emulsion injection (Yadanzi®) combined with chemotherapy in treating patients with advanced lung adenocarcinoma.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: October 03, 2013

Intrapleural or intraperitoneal lobaplatin for treatment of patients with malignant pleural effusion or ascites.

Intrapleural or intraperitoneal lobaplatin for treatment of patients with malignant pleural effusion or ascites.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: June 04, 2013

Potential predictors of sensitivity to pemetrexed as first-line chemotherapy for patients with advanced non-squamous NSCLCs.

Potential predictors of sensitivity to pemetrexed as first-line chemotherapy for patients with advanced non-squamous NSCLCs.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: May 18, 2013

Phase II study of pemetrexed as second or third line combined chemotherapy in patients with colorectal cancer.

Phase II study of pemetrexed as second or third line combined chemotherapy in patients with colorectal cancer.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: May 18, 2013

Phase II study on safety and efficacy of Yadanzi® (Javanica oil emulsion injection) combined with chemotherapy for patients with gastric cancer.

Phase II study on safety and efficacy of Yadanzi® (Javanica oil emulsion injection) combined with chemotherapy for patients with gastric cancer.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: May 18, 2013

Phase II trial of Loubo® (Lobaplatin) and pemetrexed for patients with metastatic breast cancer not responding to anthracycline or taxanes.

Phase II trial of Loubo® (Lobaplatin) and pemetrexed for patients with metastatic breast cancer not responding to anthracycline or taxanes.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: March 29, 2013

Clinical safety and efficacy of Kanglaite® (Coix Seed Oil) injection combined with chemotherapy in treating patients with gastric cancer.

Clinical safety and efficacy of Kanglaite® (Coix Seed Oil) injection combined with chemotherapy in treating patients with gastric cancer.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: December 19, 2012

Clinical study on safety and efficacy of Qinin® (cantharidin sodium) injection combined with chemotherapy in treating patients with gastric cancer.

Clinical study on safety and efficacy of Qinin® (cantharidin sodium) injection combined with chemotherapy in treating patients with gastric cancer.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: November 22, 2012

Showing 1-12 of 18

Last Updated: 09/26/2026